Abstract
Oxygenated target waters of cyclotron targets contain long-lived contaminants due to (p,n) reactions in the HAVAR target window that are spalled into the target water. These contaminants are largely removed during the synthesis of the final imaging agent. Currently the USP requires that the final drug product be 99.5% pure, so the total activity of the long-lived contaminants can be no more than 0.5% of the final radiopharmaceutical product. A method has been developed to identify and quantify the primary contaminants using high resolution gamma spectroscopy and VRF, a new spectrum analysis tool. Uptake, retention, and excretion functions for each of the contaminating isotopes in a soluble, injected chemical form have also been calculated using International Commission on Radiological Protection (ICRP) Publication 123 models and are presented in the Appendices A and B of Electronic Supplementary Material. In addition, specific organ and effective dose coefficients were also calculated using ICRP Publication 103 tissue weighting factors and are also presented in the Appendices A and B of Electronic Supplementary Material. Typical imaging agents have contaminant loads far below the USP limit and contribute negligible doses to the patients receiving the drugs.
Original language | English |
---|---|
Pages (from-to) | 7-10 |
Number of pages | 4 |
Journal | Journal of Radioanalytical and Nuclear Chemistry |
Volume | 318 |
Issue number | 1 |
DOIs | |
State | Published - Oct 1 2018 |
Keywords
- Gamma spectroscopy
- Internal dosimetry
- Patient dose
- Radiopharmaceuticals